Reliability, validity, and clinical utility of the migraine-ACT questionnaire

Headache

Volumn 46, Issue 4, 2006, Pages 553-562

  Kilminster, Shaun G ^b   Dowson, Andrew J ^a,g   Tepper, Stewart J ^c   Baos, Vicente ^d   Baudet, Francis ^e   D'Amico, Domenico ^f  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b INSTITUTE OF NAVAL MEDICINE   (United Kingdom)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

^d CS Collado Villalba   (Spain)

^e Schmerztherapie Zentrum Aachen Sud   (Germany)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

^g Ludshott End   (United Kingdom)

Author keywords

Acute treatment; Clinical utility; Migraine; Outcome tool; Reliability; Validity

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DRUG SUBSTITUTION; GENERAL PRACTITIONER; MIGRAINE; MIGRAINE ASSESSMENT OF CURRENT THERAPY QUESTIONNAIRE; MIGRAINE DISABILITY ASSESSMENT QUESTIONNAIRE; MIGRAINE THERAPY ASSESSMENT QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SHORT FORM 36; TEST RETEST RELIABILITY;

ACUTE DISEASE; HUMANS; MEDICAL HISTORY TAKING; MIGRAINE DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 33645458929     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00403.x     Document Type: Article

References (28)

1. Edmeads J Findlay H Tugwell P et al. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: A Canadian population survey Can J Neurol Sci 1993 20 131 137
2. Stang PE Von Korff M The diagnosis of headache in primary care: Factors in the agreement of clinical and standardized diagnoses Headache 1994 34 138 142
3. Celentano DD Stewart WF Lipton RB et al. Medication use and disability among migraineurs: A national probability sample survey Headache 1992 32 223 228
4. MacGregor EA Brandes J Eickermann A Migraine prevalence and treatment patterns: The global Migraine and Zolmitriptan Evaluation survey Headache 2003 43 19 26
5. Dueland AN Leira R De Vries J et al. A multinational study of migraine treatment patterns among young, active women: The Migraine Effect on Life and Treatment (MELT) study Headache Care 2004 1 19 21
6. Lipton RB Scher A Steiner TJ et al. Patterns of healthcare utilization for migraine in England and in the United States Neurology 2003 60 441 448
7. Lipton RB Dodick D Sadovsky R et al. A self-administered screener for migraine in primary care: The ID Migraine validation study Neurology 2003 61 375 382
8. Cady RK Borchert LD Spalding W et al. Simple and efficient recognition of migraine with 3-question headache screen Headache 2004 44 323 327
9. Lipton RB Stewart WF Sawyer J et al. Clinical utility of an instrument assessing migraine disability: The Migraine Disability Assessment (MIDAS) questionnaire Headache 2001 41 854 861
10. Kosinski M Bayliss MS Bjorner JB et al. A six-item short-form survey for measuring headache impact: The HIT-6 Qual Life Res 2003 12 963 974
11. Stewart WF Shechter A Lipton RB Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration Neurology 1994 44 suppl 4 24 39
12. 1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials Lancet 2001 358 1668 1675
13. International Headache Society Clinical Trials Subcommittee Guidelines for controlled trials of drugs in migraine: Second edition Cephalalgia 2000 20 765 786
14. Lipton RB Goadsby PJ Sawyer JPC et al. Migraine: Diagnosis and assessment of disability Rev Contemp Pharmacother 2000 11 63 73
15. Stewart WF Lipton RB Whyte J et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score Neurology 1999 53 988 994
16. ©. Outcome measures compared Int J Pharm Med 2003 17 23 32
17. Dowson AJ Tepper SJ Baos V et al. Identifying patients who require a change in their acute migraine treatment: The Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire Curr Med Res Opin 2004 20 1125 1135
18. D'Amico D Mosconi P Genco S The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of Italian version Cephalalgia 2001 21 947 952
19. Stewart WF Lipton RB Simon D et al. Validity of an illness severity measure in a population sample of migraine headache sufferers Pain 1999 79 291 301
20. Evers S Ruschenschmidt J Frese A et al. Impact of antimigraine compounds on cognitive processing: A placebo-controlled crossover study Headache 2003 43 1102 1108
21. Pilgrim AJ Methodology of clinical trials of sumatriptan in migraine and cluster headache Eur Neurol 1991 31 295 299
22. Adelman JU Lipton RB Ferrari MD et al. Comparison of rizatriptan and other triptans on stringent measures of efficacy Neurology 2001 57 1377 1383
23. Charlesworth BR Dowson AJ Purdy A et al. Speed of onset and efficacy of zolmitriptan nasal spray in the treatment of migraine: A randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet CNS Drugs 2003 17 653 667
24. Anonymous Checklist migraine Available at
25. Anonymous Norm-based scoring of SF-36 scales In SF-36 Summary Measures Manual Lincoln RI Qualitymetric, Inc. 2003 22 35
26. Stewart WF Lipton RB Dowson AJ et al. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability Neurology 2001 56 suppl 1 S20 S28
27. Chatterton ML Lofland JH Shechter A et al. Reliability and validity of the Migraine Therapy Assessment questionnaire Headache 2002 42 1006 1015
28. Tepper SJ Dahlöf CGH Dowson A et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: Data from the Landmark Study Headache 2004 44 856 864